MTP-131
Showing 1 - 25 of 265
Leber's Hereditary Optic Neuropathy Trial in Pasadena (elamipretide (MTP-131) 1% topical ophthalmic solution, Vehicle topical
Completed
- Leber's Hereditary Optic Neuropathy
- elamipretide (MTP-131) 1% topical ophthalmic solution
- Vehicle topical ophthalmic solution
-
Pasadena, CaliforniaDoheny Eye Center
Nov 29, 2021
Barth Syndrome Trial in Baltimore (Elamipretide)
Completed
- Barth Syndrome
-
Baltimore, MarylandMcKusick-Nathans Institute of Genetic Medicine, Johns Hopkins Un
Mar 7, 2022
Skeletal Muscle Mitochondrial Dysfunction in the Elderly Trial in Seattle (Elamipretide, Placebo)
Completed
- Skeletal Muscle Mitochondrial Dysfunction in the Elderly
- Elamipretide
- Placebo
-
Seattle, WashingtonThe University of Washington Medical Center
Jun 20, 2020
Primary Mitochondrial Disease Trial in United States (Elamipretide, Placebo)
Completed
- Primary Mitochondrial Disease
- Elamipretide
- Placebo
-
San Diego, California
- +3 more
Jul 6, 2020
Mitochondrial Myopathy Trial in United States (elamipretide (low dose), elamipretide (intermediate dose), elamipretide (high
Completed
- Mitochondrial Myopathy
- elamipretide (low dose)
- +3 more
-
San Diego, California
- +3 more
Dec 8, 2019
Age-Related Macular Degeneration Trial in Durham (Elamipretide)
Completed
- Age-Related Macular Degeneration
-
Durham, North CarolinaDuke University School of Medicine / Dept. of Ophthalmology (Duk
Sep 28, 2020
Reperfusion Injury, STEMI Trial in Worldwide (Bendavia (MTP-131), Placebo)
Completed
- Reperfusion Injury
- STEMI
- Bendavia (MTP-131)
- Placebo
-
Port Orange, Florida
- +29 more
May 31, 2020
Renal Artery Obstruction, Hypertension, Renovascular, Ischemia Reperfusion Injury Trial in Rochester (Bendavia, Placebo)
Terminated
- Renal Artery Obstruction
- +2 more
- Bendavia
- Placebo
-
Rochester, MinnesotaMayo Clinic
Aug 10, 2020
Primary Mitochondrial Myopathy Trial in Worldwide (elamipretide, comparator, elamipretide open label treatment)
Terminated
- Primary Mitochondrial Myopathy
- elamipretide
- +2 more
-
La Jolla, California
- +26 more
Jan 16, 2022
Massive Transfusion in Trauma Patient Registry
Recruiting
- Trauma
- blood products as a part of Massive Transfusion Protocol
-
Dallas, TexasMethodist Dallas Medical Center
Nov 13, 2023
Thyroid Cancer, Thyroid Carcinoma, Metastatic Thyroid Cancer Trial in Boston (Selpercatinib, Sodium Iodine I-131, rhTSH)
Not yet recruiting
- Thyroid Cancer
- +5 more
- Selpercatinib
- +2 more
-
Boston, MassachusettsMassachusetts General Hospital
Dec 20, 2022
Osteosarcoma Trial in New York (L-MTP-PE)
Available
- Osteosarcoma
-
New York, New YorkMemorial Sloan Kettering Cancer Center (All Protocol Activities)
May 19, 2022
Locally Advanced Solid Tumors, Metastatic Solid Tumors Trial in Edmonton ([131]I-IAZA)
Withdrawn
- Locally Advanced Solid Tumors
- Metastatic Solid Tumors
-
Edmonton, Alberta, CanadaCross Cancer Institute
Jul 7, 2022
Waldenstrom Macroglobulinemia, Multiple Myeloma, Chronic Lymphocytic Leukemia Trial in Worldwide (Iopofosine I 131 single dose,
Recruiting
- Waldenstrom Macroglobulinemia
- +8 more
- Iopofosine I 131 single dose
- +2 more
-
Redlands, California
- +42 more
Dec 30, 2022
Ganglioneuroblastoma, Neuroblastoma Trial in Canada, Puerto Rico, United States (procedure, drug, biological, radiation)
Recruiting
- Ganglioneuroblastoma
- Neuroblastoma
- Autologous Hematopoietic Stem Cell Transplantation
- +18 more
-
Birmingham, Alabama
- +158 more
Sep 14, 2022
The Turkish Version of the AOFAS Hallux MTP-IP
Completed
- Foot Deformity
- +3 more
-
Istanbul, Bakırkoy, TurkeyIstanbul University-Cerrahpasa
Apr 12, 2022
Renal Tracer Elimination in Thyroid Cancer Patients Treated With
Completed
- Thyroid Carcinoma
-
Jena, Thüringen, GermanyUniversity Hospital Jena
Dec 15, 2022
Risk for Reoperation After First MTP Joint Arthrodesis
Active, not recruiting
- Hallux Rigidus
- +4 more
- First metatarsophalangeal joint arthrodesis
-
Helsinki, FinlandHelsinki University Hospital
Mar 21, 2023
Nicotine Dependence, Cigarettes, Uncomplicated Trial in Providence (Very Low Nicotine Content Cigarettes, Normal Nicotine
Completed
- Nicotine Dependence, Cigarettes, Uncomplicated
- Very Low Nicotine Content Cigarettes
- Normal Nicotine Content Cigarettes
-
Providence, Rhode IslandBrown University School of Public Health
Nov 3, 2022
B-ALL, DLBCL, B ALL Trial in New York (131-I Apamistamab, CAR T-cell)
Recruiting
- B-ALL
- +10 more
- 131-I Apamistamab
- CAR T-cell
-
New York, New YorkMemorial Sloan Kettering Cancer Center
Mar 7, 2022